Kyle Bass fires off two more IPR petitions


Hedge fund manager Kyle Bass and his Coalition for Affordable Drugs are continuing their campaign against certain pharmaceutical patents, most recently seeking to invalidate patents owned by Celgene and NPS Pharma.

Kyle Bass, Coalition for Affordable Drugs, Celgene, NPS Pharma, inter partes review